Molecular probes for multimodality imaging and tracking of stem cells
US-9492571-B2 · Nov 15, 2016 · US
US9987380B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9987380-B2 |
| Application number | US-201213549309-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 13, 2012 |
| Priority date | Jul 15, 2011 |
| Publication date | Jun 5, 2018 |
| Grant date | Jun 5, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition useful as a PET and/or fluorescence imaging probe a compound a compound of Formula I, including salts, hydrates and solvates thereof: wherein R 1 -R 7 may be independently selected from hydrogen, halogen, hydroxy, alkoxy, nitro, substituted and unsubstituted amino, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, X is selected from the group consisting of C and N; and A is selected of hydrogen, halogen, hydroxy, alkoxy, nitro, substituted and unsubstituted amino, alkyl, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, including phenyl and aminophenyl, and heteroaryl.
Opening claim text (preview).
We claim: 1. A composition having an imaging probe therein comprising: the lewis acid SnCl 4 ; and at least one compound selected from the group consisting of compounds of Formula I, including salts, hydrates and solvates thereof: the compounds of Formula X, including salts, hydrates and solvates thereof the compounds of Formula XII, including salts, hydrates and solvates thereof wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 may be independently selected from one or more of the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitro, substituted and unsubstituted amino, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, including phenyl and aminophenyl, azide, alkyne and heteroaryl; X is selected from the group consisting of C and N; A is selected from one or more of the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitro, and substituted and unsubstituted amino, alkyl, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, including phenyl and aminophenyl, and heteroaryl. 2. The composition according to claim 1 , wherein the composition comprises at least one compound of Formula I, including salts, hydrates and solvates thereof: wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 may be independently selected from one or more of the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitro, substituted and unsubstituted amino, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, including phenyl and aminophenyl, azide, alkyne and heteroaryl; X is selected from the group consisting of C and N; A is selected from one or more of the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitro, and substituted and unsubstituted amino, alkyl, cycloalkyl, carboxy, carboxylic acids and esters thereof, cyano, haloalkyl, aryl, including phenyl and aminophenyl, and heteroaryl. 3. The composition according to claim 2 , wherein the composition comprises at least one compound selected from the group consisting of Formulas IV and VI, including salts, hydrates and solvates thereof: 4. The composition according to claim 3 , further comprising at least one compound selected from the group consisting of: wherein at least one of the fluorines in a B—F bond in the compound is 18 F. 5. The composition according to claim 1 , wherein the compound is conjugated to a targeting moiety. 6. The composition according to claim 5 , wherein the compound is a compound according to Formula 1, including salts, hydrates and solvates thereof: 7. The composition according to claim 6 , wherein the targeting moiety is a peptide. 8. The composition according to claim 7 , wherein the targeting moiety is an RGD peptide. 9. The composition according to claim 8 , wherein the targeting moiety is a cyclic RGD peptide. 10. The composition according to claim 7 , wherein the peptide is selected from the group consisting of:
the fluorescent group being a small organic molecule · CPC title
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title
having six-membered rings with one nitrogen as the only ring hetero atom · CPC title
without C-boron linkages · CPC title
General or multifunctional contrast agents, e.g. chelated agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.